These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 33966657)

  • 1. A Market Shaping Approach for the Biopharmaceutical Industry: Governing Innovation Towards the Public Interest.
    Mazzucato M; Li HL
    J Law Med Ethics; 2021; 49(1):39-49. PubMed ID: 33966657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biopharmaceutical process development - shortcut to market: an interview with Rolf Werner from Boehringer Ingelheim.
    Jungbauer A; Göbel U
    Biotechnol J; 2012 Jan; 7(1):14-6. PubMed ID: 22228694
    [No Abstract]   [Full Text] [Related]  

  • 3. Avoiding exploitation in clinical research.
    Benatar SR
    Camb Q Healthc Ethics; 2000; 9(4):562-5. PubMed ID: 11000973
    [No Abstract]   [Full Text] [Related]  

  • 4. Emergence of biopharmaceutical innovators in China, India, Brazil, and South Africa as global competitors and collaborators.
    Rezaie R; McGahan AM; Frew SE; Daar AS; Singer PA
    Health Res Policy Syst; 2012 Jun; 10():18. PubMed ID: 22672351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The roles of patents and research and development incentives in biopharmaceutical innovation.
    Grabowski HG; DiMasi JA; Long G
    Health Aff (Millwood); 2015 Feb; 34(2):302-10. PubMed ID: 25646111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Challenges to sovereign ambitions: forces of convergence and divergence within the global pharmaceutical sector and the UK's withdrawal from the European Union.
    Wright JSF; Doukas D
    Health Econ Policy Law; 2021 Jul; 16(3):256-272. PubMed ID: 32583755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mechanism and implication of regulation of the pricing of essential medicines in the private pharmaceutical sector in Mali].
    Maïga D; Maïga S; Maïga MD
    Med Trop (Mars); 2010 Apr; 70(2):184-8. PubMed ID: 20486360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. With the help of a foreign ally: biopharmaceutical innovation in India after TRIPS.
    Angeli F
    Health Policy Plan; 2014 May; 29(3):280-91. PubMed ID: 23558959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The patents-based pharmaceutical development process: rationale, problems, and potential reforms.
    Barton JH; Emanuel EJ
    JAMA; 2005 Oct; 294(16):2075-82. PubMed ID: 16249422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The importance of patents to innovation: updated cross-industry comparisons with biopharmaceuticals.
    Cockburn I; Long G
    Expert Opin Ther Pat; 2015 Jul; 25(7):739-42. PubMed ID: 25927945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does process excellence handcuff drug development?
    Koenig J
    Drug Discov Today; 2011 May; 16(9-10):377-81. PubMed ID: 21349347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Property rights go East.
    Nature; 2005 Nov; 438(7067):420-1. PubMed ID: 16306959
    [No Abstract]   [Full Text] [Related]  

  • 13. The Trans-Pacific Partnership and pharmaceutical innovation.
    Freeman RA
    Res Social Adm Pharm; 2016; 12(4):633-7. PubMed ID: 26803645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Needs-driven versus market-driven pharmaceutical innovation: the consortium for the development of a new medicine against malaria in Brazil.
    Kameda K
    Dev World Bioeth; 2014 Aug; 14(2):101-8. PubMed ID: 24761744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The dilemma of intellectual property rights for pharmaceuticals: the tension between ensuring access of the poor to medicines and committing to international agreements.
    Cohen JC; Illingworth P
    Dev World Bioeth; 2003 May; 3(1):27-48. PubMed ID: 14577451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. INTRODUCTION: Public Sector and Non-Profit Contributions to Drug Development - Historical Scope, Opportunities, and Challenges.
    Sarpatwari A; Kesselheim AS
    J Law Med Ethics; 2021; 49(1):6-9. PubMed ID: 33966663
    [No Abstract]   [Full Text] [Related]  

  • 17. [Commercialization of results of intellectual activities in pharmaceutical industry].
    Posylkina OV; Timaniuk VN; Gladukh EV
    Lik Sprava; 2002; (8):16-9. PubMed ID: 12669531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ownership of knowledge--the role of patents in pharmaceutical R&D.
    Correa CM
    Bull World Health Organ; 2004 Oct; 82(10):784-7; discussion 787-90. PubMed ID: 15643801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of the private sector in biotechnology: research and development.
    Feisee L
    Health Matrix Clevel; 2002; 12(2):357-65. PubMed ID: 12430359
    [No Abstract]   [Full Text] [Related]  

  • 20. Patents or patients? Global access to pharmaceuticals and social justice.
    de Wildt G; Khoon CC
    Med Confl Surviv; 2008; 24 Suppl 1():S52-61. PubMed ID: 18771195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.